About Mirati Therapeutics

Mirati Therapeutics, Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet medical need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Unified for patients, Mirati's vision is to unlock the science behind the promise of a life beyond cancer.

For more information about Mirati Therapeutics Inc., visit us at Mirati.com.

Read our guidelines for interacting with Mirati on social media here: https://bit.ly/3lFIWB0.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
3545 Cray Ct, San Diego, California 92121, US
description icon
Founded
2013

Mirati Therapeutics Alternatives

Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Mirati Therapeutics

Who is the CEO of Mirati Therapeutics?

David Meek is the CEO of Mirati Therapeutics. To contact David Meek email at [email protected].

Who are the decision makers in Mirati Therapeutics?

The decision makers in Mirati Therapeutics are David Meek, David Rubin, James Christensen, etc. Click to Find Mirati Therapeutics decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more